Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Research buzz > Delaying second Pfizer-BioNTech dose could leave cancer patients with insufficient immunity

Delaying second Pfizer-BioNTech dose could leave cancer patients with insufficient immunity

Researchers from the Crick and Imperial College have started work on a new study, funded by Kidney Research UK and the National Kidney Federation.
15 Mar 2021
United Kingdom
Research buzz

To view this News Article please log in or create a profile

Similar stories

Researchers at the Crick and UCL have developed a tool to analyse a key set of genes linked to the ability of cancer cells to hide from the body’s immune system. More...

Researchers at the Crick have shown that the balance of bacteria in the gut can influence symptoms of hypopituitarism in… More...

Researchers at the Crick have identified a key gene for the renewal of cells in the mouse intestine to repair the gut af… More...

Researchers in the Chromosome Segregation Laboratory and the Mechanobiology and Biophysics Laboratory have proposed a ne… More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk


This website is powered by
ToucanTech